Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Bloomberg Markets

Drugmaker Parabilis Raises $745 Million in US IPO, Placement

Drugmaker Parabilis Raises $745 Million in US IPO, Placement
ShareXFacebook

Parabilis Medicines Inc., a clinical-stage cancer drug developer, raised nearly $745 million in an upsized US initial public offering that priced above its marketed range, and a private placement.

B

Source

Bloomberg Markets

Read full article at Bloomberg Markets

Opens original article in a new tab

Advertisement

Related Economy Stories

E Fund’s Li: Market Sentiment ‘Cautiously Optimistic’
Bloomberg Markets

E Fund’s Li: Market Sentiment ‘Cautiously Optimistic’

Jeff Li, Global Equity CIO at E Fund HK, says he expects technology fundamentals to drive equity markets as the macro environment becomes “relatively tighter.” He speaks with David Ingles from the sidelines of “Bloomberg Invest Hong Kong.” (Source: Bloomberg)

Read more →
Advertisement